MDSANZ Annual Scientific Meeting 2019

15 – 17 November 2019, Adelaide Convention Centre, Adelaide

Our Sponsors

Gold sponsors

           
            
            
            
            Website: www.seqirus.com.au

Seqirus

Seqirus, a CSL company, is a leading provider of essential vaccines and pharmaceuticals. We have served Australia's healthcare needs for over a century and today we develop, manufacture and source medicines that support the health and wellbeing of many thousands of people around the world.

Seqirus operates Australia's only local manufacturing facility for seasonal and pandemic influenza vaccine and produces a range of unique medicines in the National Interest including antivenoms and Q fever vaccine.

Seqirus also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products including Xadago™ (safinamide) and Teglutik® (riluzole).



           
                        
                        
                        
                        Website: www.ucbaustralia.com.au

UCB Australia

UCB aspires to be the patient-centric global biopharmaceutical leader, transforming the lives of people with severe diseases.

At UCB our sense of purpose is to help people suffering from severe central nervous system disorders lead normal, everyday lives. Our ambition is to offer them innovative new medicines and ground-breaking solutions that go beyond the drug. We are committed to enabling cutting-edge scientific research that is driven by patients' needs.            

Silver and Coffee Cart sponsors





Website: www.merz.australia.com.au

Merz Australia Pty Ltd

With approximately 3000 employees and a direct presence in 28 countries, Merz is a global, family-owned aesthetics and neurotoxin company inspired by more than 110 years of innovation, commitment and trust. Driven by the opportunity to help people look better, feel better and live better, Merz earns the confidence of clinicians in aesthetics and neuroscience with a relentless focus on customer service to providers and overall satisfaction for patients.

As a family-owned company, Merz values personal relationships; we recognize that our obligation is to understand the needs of our physician customers, so we can help them best serve their patients. You see it in how we engage with our customers in every aspect of our business. You see it in our holistic portfolio of products. And you'll see it in the innovations that are already expanding that portfolio.

From our scientific expertise developed over more than a century, to our focus on customer needs, the Merz way means your success is our success.

In fiscal year 2017/2018 Merz generated revenue of EUR 1024.4 m. More information can be found at www.merz.australia.com.au






Website: www.pfizer.com.au

Pfizer Australia

Breakthroughs that change patients' lives™

Throughout Pfizer's 170 year history, and over 60 years in Australia, we have remained dedicated to discovering and developing new and better ways to prevent and treat disease, and improve the health and wellbeing of people around the world.

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world's best-known consumer products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world


Silver sponsors

           
            
            
            
            Website: www.aus.abbott

Abbott

Abbott is a globally diversified healthcare company with a central purpose to help people live their healthiest possible lives. Abbott's Neuromodulation business is transforming the treatment of chronic pain and movement disorders through innovation, clinical leadership, and life-changing technology. Our therapeutic technology touches millions of people every day. We see it as an opportunity to continue innovating and to keep improving lives. And we hope it can improve yours. Our chronic pain therapies can help people be active and productive again, while reducing healthcare costs and reliance on pain medication. Our therapies for movement disorders, such as Parkinson's disease and essential tremor, can provide greater independence and control by delivering effective symptom management.







Website: www.abbvie.com.au

AbbVie

As a new biopharmaceutical company, AbbVie combines the expertise of a recognised pharmaceutical company with the focus and innovative spirit of a biotech. Through a targeted, patient-centric approach to research and development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases in the world, while our services and partnerships help us create greater access and outcomes for the health of all Australians.

We focus on discovering, developing, and delivering medicines in therapeutic areas where we have proven expertise and where we can have an impact. These areas include: Immunology, Oncology, Virology and Neuroscience. Within Neuroscience we focus on the treatment of advanced Parkinson's disease, and continue to drive improved patient outcomes for this patient group.







Website: www.allergan.com

Allergan

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science, to develop and deliver innovative and meaningful treatments to help people reach their life's potential. We have highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries.

A rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly; move more freely; and express themselves more fully. From our beginnings as an eye care company to our focus today on several medical specialties, the Allergan portfolio features 6 franchises in key therapeutic categories including Dermatology and Medical Aesthetics, CNS, Eye Care, Women's Health and Urology, GI and Cystic Fibrosis, Cardiovascular and Infectious Disease.

Allergan is proud to celebrate more than 60 years of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work.







Website: www.bostonscientific.com

Boston Scientific

Boston Scientific (NYSE: BSX) transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

We are dedicated to transforming the lives of patients by delivering meaningful innovations for the most challenging neurological disorders. A leading provider and developer of high performance Neuromodulation therapies, we have a long history of closely collaborating with neurosurgeons and pain physicians who treat neurological disorders. 



           
            
            
            
            Website: www.brainlab.com

Brainlab Australia

Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 12,850 systems installed in over 100 countries. Brainlab employs almost 1,400 people in 18 offices worldwide, including more than 420 Research & Development engineers, who form a crucial part of the product development team. 



           
            
            
            
            Website: www.globalkineticscorp.com
            
           

Global Kinetics Pty Ltd

Global Kinetics is continuing to transform the management of Parkinson's disease (PD) with its lead product, the Parkinson's KinetiGraph® (PKG® or Personal KinetiGraph® as it is known in the USA), a patient-friendly, algorithm-based system that records patients' movements over the course of several days and creates data-driven reports that empowers more personalised treatment and management decisions-ultimately leading to a higher quality of life for patients. 





Website: www.ipsen.com

Ipsen

Ipsen provides specialty medicines and quality services to Healthcare Professional and their patients suffering from debilitating disease.

At Ipsen, our passion is improving the lives of patients. We do this by working together to build partnerships based on trust and mutual respect with Healthcare Professionals. We deliver tailored solutions through our agility and innovation and we strive to be even better tomorrow than we are today.

Ipsen Pty Ltd is the Australian affiliate of a global R & D focused pharmaceutical company.


           
            
            
            
            Website: www.medtronic.com
            
           

Medtronic

Making healthcare better is our priority, and we believe medical technology can play an even greater role in improving people's lives. With challenges facing families and healthcare systems - such as rising costs, aging populations, and the burden of chronic disease - we are using the power of technology to take healthcare Further, Together.

Innovation and collaboration are central to who we are. Since the late 1940s, we have been working with others to alleviate pain, restore health, and extend life. Today, we are a medical technology leader, employing more than 84,000 people worldwide, and offering therapies and solutions that enable greater efficiency, access, and value - for healthcare systems, providers, and the people they serve. Learn more at Medtronic.com. 



           
            
            
            
            Website: www.stada.com.au

STADA Pharmaceuticals

STADA Australia is a speciality pharmaceutical company with a product focus on infusion therapies in Neurology and Pain Management.

We work closely with Britannia Pharmaceuticals in the UK, a wholly owned subsidiary of STADA, to ensure the latest innovative therapies and advancements in Europe are brought to Australia and New Zealand for Parkinson's disease.

In August 2016, STADA Australia and BioQ Pharma Incorporated announced a strategic partnership to commercialise three ready-to-use infusion pharmaceuticals in Australia and New Zealand for post-operative pain management.

Movement Disorders Skills Workshop sponsor





Website: www.pfizer.com.au

Pfizer Australia

Breakthroughs that change patients' lives™

Throughout Pfizer's 170 year history, and over 60 years in Australia, we have remained dedicated to discovering and developing new and better ways to prevent and treat disease, and improve the health and wellbeing of people around the world.

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world's best-known consumer products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world

Saturday afternoon tea sponsor

           
            
            
            
            Website: www.tevapharma.com.au

 

Teva

We are committed to providing innovative and high-quality medicines to the 200 million people we serve around the world every day - touching patients, families and communities to improve health and make better days.